Drug
Telmisartan And Hydrochlorothiazide
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Hypertensive Crisis | 21 | 16.8 | 16.9 | signal |
| 2 | Sinus Bradycardia | 11 | 10.1 | 10.2 | signal |
| 3 | Coronary Artery Occlusion | 14 | 9.1 | 9.1 | signal |
| 4 | Blood Pressure Abnormal | 19 | 8.6 | 8.6 | signal |
| 5 | Blood Sodium Decreased | 18 | 8.5 | 8.6 | signal |
| 6 | Tendon Rupture | 10 | 7.2 | 7.2 | signal |
| 7 | Hyponatraemia | 43 | 6.8 | 6.9 | signal |
| 8 | Sleep Apnoea Syndrome | 14 | 6.5 | 6.6 | signal |
| 9 | Blood Potassium Decreased | 22 | 6.5 | 6.6 | signal |
| 10 | Renal Failure Acute | 31 | 6.4 | 6.5 | signal |
| 11 | Blood Pressure Increased | 104 | 6.0 | 6.3 | signal |
| 12 | Dry Throat | 6 | 5.3 | 5.3 | signal |
| 13 | Sluggishness | 6 | 5.3 | 5.3 | signal |
| 14 | Macular Degeneration | 7 | 5.2 | 5.2 | signal |
| 15 | Pollakiuria | 24 | 5.1 | 5.2 | signal |
| 16 | Orthostatic Hypotension | 10 | 5.1 | 5.1 | signal |
| 17 | Carpal Tunnel Syndrome | 8 | 5.1 | 5.1 | signal |
| 18 | Gout | 10 | 5.0 | 5.0 | signal |
| 19 | Spinal Disorder | 5 | 4.7 | 4.7 | signal |
| 20 | Laceration | 5 | 4.7 | 4.7 | signal |
| 21 | Sinus Congestion | 7 | 4.6 | 4.6 | signal |
| 22 | Knee Operation | 5 | 4.6 | 4.6 | signal |
| 23 | Vitreous Floaters | 5 | 4.6 | 4.6 | signal |
| 24 | Blood Triglycerides Increased | 9 | 4.5 | 4.5 | signal |
| 25 | Erectile Dysfunction | 13 | 4.5 | 4.5 | signal |
| 26 | Arrhythmia | 24 | 4.5 | 4.5 | signal |
| 27 | Inappropriate Antidiuretic Hormone Secretion | 5 | 4.4 | 4.4 | signal |
| 28 | Renal Pain | 5 | 4.2 | 4.2 | signal |
| 29 | Circulatory Collapse | 8 | 4.2 | 4.2 | signal |
| 30 | Lactic Acidosis | 15 | 4.2 | 4.2 | signal |
| 31 | Blood Pressure Fluctuation | 11 | 4.1 | 4.1 | signal |
| 32 | Transient Ischaemic Attack | 15 | 3.9 | 4.0 | signal |
| 33 | Heart Rate Irregular | 10 | 3.9 | 3.9 | signal |
| 34 | Glycosylated Haemoglobin Increased | 11 | 3.9 | 3.9 | signal |
| 35 | Nerve Compression | 4 | 3.9 | 3.9 | signal |
| 36 | Haematoma | 11 | 3.8 | 3.8 | signal |
| 37 | Melaena | 9 | 3.6 | 3.6 | signal |
| 38 | Salivary Hypersecretion | 4 | 3.6 | 3.6 | signal |
| 39 | Multi-organ Failure | 7 | 3.6 | 3.6 | signal |
| 40 | Diabetes Mellitus Inadequate Control | 7 | 3.5 | 3.5 | signal |
| 41 | Drug Dispensing Error | 6 | 3.4 | 3.5 | signal |
| 42 | Hair Texture Abnormal | 5 | 3.3 | 3.3 | signal |
| 43 | Lip Swelling | 12 | 3.2 | 3.2 | signal |
| 44 | Product Physical Issue | 7 | 3.1 | 3.1 | signal |
| 45 | Activities Of Daily Living Impaired | 7 | 3.1 | 3.1 | signal |
| 46 | Suicide Attempt | 20 | 2.9 | 2.9 | signal |
| 47 | Brain Neoplasm | 3 | 2.9 | 2.9 | no signal |
| 48 | Blindness | 13 | 2.8 | 2.9 | signal |
| 49 | Hunger | 4 | 2.7 | 2.7 | no signal |
| 50 | Prostatic Specific Antigen Increased | 4 | 2.6 | 2.6 | no signal |
| 51 | Local Swelling | 5 | 2.5 | 2.5 | no signal |
| 52 | Breast Cancer Metastatic | 3 | 2.5 | 2.5 | no signal |
| 53 | Convulsion | 16 | 2.5 | 2.5 | signal |
| 54 | Injection Site Nodule | 3 | 2.4 | 2.4 | no signal |
| 55 | Myocardial Infarction | 48 | 2.4 | 2.5 | signal |
| 56 | Blood Glucose Abnormal | 5 | 2.4 | 2.4 | no signal |
| 57 | Madarosis | 3 | 2.3 | 2.3 | no signal |
| 58 | Systemic Lupus Erythematosus | 9 | 2.3 | 2.3 | signal |
| 59 | Blood Glucose Decreased | 12 | 2.2 | 2.2 | signal |
| 60 | Libido Decreased | 3 | 2.2 | 2.2 | no signal |
| 61 | Multiple Fractures | 4 | 2.2 | 2.2 | no signal |
| 62 | Application Site Irritation | 3 | 2.1 | 2.1 | no signal |
| 63 | Hair Colour Changes | 3 | 2.1 | 2.1 | no signal |
| 64 | Blood Glucose Increased | 40 | 1.9 | 1.9 | no signal |
| 65 | Diabetic Ketoacidosis | 5 | 1.9 | 1.9 | no signal |
| 66 | Injection Site Haematoma | 3 | 1.8 | 1.8 | no signal |
| 67 | Intentional Drug Misuse | 4 | 1.7 | 1.7 | no signal |
| 68 | Incorrect Drug Administration Duration | 5 | 1.6 | 1.6 | no signal |
| 69 | Pancreatic Carcinoma | 5 | 1.5 | 1.5 | no signal |
| 70 | Menorrhagia | 3 | 1.3 | 1.3 | no signal |
| 71 | Application Site Erythema | 3 | 1.0 | 1.0 | no signal |
| 72 | Prostate Cancer | 9 | 1.0 | 1.0 | no signal |
| 73 | Breast Cancer | 10 | 0.9 | 0.9 | no signal |
| 74 | Dermatitis Atopic | 5 | 0.9 | 0.9 | no signal |
| 75 | Gynaecomastia | 3 | 0.9 | 0.9 | no signal |
| 76 | Renal Cancer | 3 | 0.6 | 0.6 | no signal |
| 77 | Bladder Cancer | 3 | 0.4 | 0.4 | no signal |